CordenPharma

CordenPharma describes itself as a full-service GMP CDMO for a global market, founded in 2006. It states that its capabilities are organized under six technology platforms and that it operates a network of 13 cGMP manufacturing facilities across Europe, North America and Asia, with more than 3500 employees across facilities in seven countries. Its stated services span the complete supply chain, from early clinical-phase development to commercialization, covering APIs, drug products, and lipid excipients and nanomedicines.

CordenPharma states that it was founded in 2006, with a mission to support global pharmaceutical and biotechnology customers with high quality products for the well-being of patients. It describes its capabilities as organized under six technology platforms, each led by a Platform Director, and reports a fully integrated network of 13 cGMP manufacturing facilities across Europe, North America and Asia, with more than 3500 employees across facilities in seven countries.

• 2022-02-01

  CordenPharma completes acquisition of three Vifor Pharma manufacturing facilities[5]CordenPharma 完成收购 Vifor Pharma 的三处制造设施prnewswire.com

  Reported: 2022-02-01

  CordenPharma completed its acquisition of three manufacturing facilities from Vifor Pharma, located in Switzerland and Portugal.

1. 1CordenPharma | Full-Service GMP CDMO for a Global Marketcordenpharma.com
2. 2Pharma Primary & Secondary Packaging Solutions | CordenPharmacordenpharma.com
3. 3About Us | CordenPharmacordenpharma.com
4. 4Quality | About Us | CordenPharmacordenpharma.com
5. 5CordenPharma 完成收购 Vifor Pharma 的三处制造设施prnewswire.com
6. 6CordenPharma Completes Acquisition of Three Manufacturing Facilities from Vifor Pharma - PRN India News - Webindia123.comnews.webindia123.com